首页|期刊导航|中华医学杂志(英文版)|Impact of thymosin α1 as an immunomodulatory therapy on long-term survival of non-small cell lung cancer patients after RO resection:a propensity score-matched analysis
Impact of thymosin α1 as an immunomodulatory therapy on long-term survival of non-small cell lung cancer patients after RO resection:a propensity score-matched analysis
Cheng-Lin Guo Xing Sun Lun-Xu Liu Jian-Dong Mei Yu-Long Jia Fan-Yi Gan Yu-Dong Tang Cheng-Wu Liu Zhen Zeng Zhen-Yu Yang Sen-Yi Deng
中华医学杂志(英文版)2021,Vol.134Issue(22):2700-2709,10.
中华医学杂志(英文版)2021,Vol.134Issue(22):2700-2709,10.DOI:10.1097/CM9.0000000000001819
Impact of thymosin α1 as an immunomodulatory therapy on long-term survival of non-small cell lung cancer patients after RO resection:a propensity score-matched analysis
Impact of thymosin α1 as an immunomodulatory therapy on long-term survival of non-small cell lung cancer patients after RO resection:a propensity score-matched analysis
摘要
关键词
Non-small cell lung cancer/Resection/Adjuvant therapy/Thymosin α1Key words
Non-small cell lung cancer/Resection/Adjuvant therapy/Thymosin α1引用本文复制引用
Cheng-Lin Guo,Xing Sun,Lun-Xu Liu,Jian-Dong Mei,Yu-Long Jia,Fan-Yi Gan,Yu-Dong Tang,Cheng-Wu Liu,Zhen Zeng,Zhen-Yu Yang,Sen-Yi Deng..Impact of thymosin α1 as an immunomodulatory therapy on long-term survival of non-small cell lung cancer patients after RO resection:a propensity score-matched analysis[J].中华医学杂志(英文版),2021,134(22):2700-2709,10.基金项目
This study was supported by grants from the 1.3.5 project for disciplines of excellence,West China Hospital,Sichuan University (Nos.ZYGD18021 and ZYJC18009). (Nos.ZYGD18021 and ZYJC18009)